TrialMolecular cancer therapeutics2016

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.

Melissa J LaBonte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.